These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36138408)

  • 1. Concordance of three point of care testing devices with clinical chemistry laboratory standard assays and patient-reported outcomes of blood sampling methods.
    Yonel Z; Kuningas K; Sharma P; Dutton M; Jalal Z; Cockwell P; Webber J; Narendran P; Dietrich T; Chapple ILC
    BMC Med Inform Decis Mak; 2022 Sep; 22(1):248. PubMed ID: 36138408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting.
    Yonel Z; Yahyouche A; Jalal Z; James A; Dietrich T; Chapple ILC
    BMC Public Health; 2020 Oct; 20(1):1576. PubMed ID: 33081745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation.
    Corbett M; Duarte A; Llewellyn A; Altunkaya J; Harden M; Harris M; Walker S; Palmer S; Dias S; Soares M
    Health Technol Assess; 2020 Aug; 24(39):1-248. PubMed ID: 32840478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-creation process of an intervention to implement a multiparameter point-of-care testing device in a primary healthcare setting for non-communicable diseases in Peru.
    Albitres-Flores L; Perez-Leon S; Bernabe-Ortiz A; Tenorio-Mucha J; Cardenas MK; Vetter B; Safary E; Gamboa R; Cordova V; Gupta R; Moran A; Beran D; Lazo-Porras M
    BMC Health Serv Res; 2024 Mar; 24(1):401. PubMed ID: 38553724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of POCT in the diabetic clinic in a large hospital.
    Tanyanyiwa D; Dandara C; Bhana SA; Pauly B; Marule F; Ramokoka M; Bwititi P; Nwose U; Nkosi B
    Afr Health Sci; 2015 Sep; 15(3):902-7. PubMed ID: 26957980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community paramedic point of care testing: validity and usability of two commercially available devices.
    Blanchard IE; Kozicky R; Dalgarno D; Simms J; Goulder S; Williamson TS; Biesbroek S; Page L; Leaman K; Snozyk S; Redman L; Spackman K; Doig CJ; Lang ES; Lazarenko G
    BMC Emerg Med; 2019 May; 19(1):30. PubMed ID: 31046680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Point-of-Care Testing Compared with the Standard Laboratory Diagnostic Test in the Measurement of HbA1c in Indonesian Diabetic and Nondiabetic Subjects.
    Berbudi A; Rahmadika N; Tjahjadi AI; Ruslami R
    J Diabetes Res; 2020; 2020():2037565. PubMed ID: 32733964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-Care Testing Using Invasive and Non-Invasive Hemoglobinometers: Reliable and Valid Method for Estimation of Hemoglobin among Children 6-59 Months.
    Ramaswamy G; Vohra K; Yadav K; Kaur R; Rai T; Jaiswal A; Kant S
    J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33367788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
    Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
    Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point-of-Care Testing in Chronic Kidney Disease of Non-Traditional Origin: Considerations for Clinical, Epidemiological, and Health Surveillance Research and Practice.
    Dally M; Amador JJ; Butler-Dawson J; Lopez-Pilarte D; Gero A; Krisher L; Cruz A; Pilloni D; Kupferman J; Friedman DJ; Griffin BR; Newman LS; Brooks DR
    Ann Glob Health; 2023; 89(1):7. PubMed ID: 36789382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical and clinical performance of three hand-held point-of-care creatinine analyzers for renal function measurements prior to contrast-enhanced imaging.
    van der Heijden C; Roosens L; Cluckers H; Van Craenenbroeck AH; Peeters B
    Clin Chim Acta; 2019 Oct; 497():13-19. PubMed ID: 31271741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program.
    Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G
    Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HbA
    Dubach IL; Christ ER; Diem P
    Prim Care Diabetes; 2019 Dec; 13(6):583-587. PubMed ID: 31175054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of a Point-of-Care Hemoglobin A1c Assay.
    Nathan DM; Griffin A; Perez FM; Basque E; Do L; Steiner B
    J Diabetes Sci Technol; 2019 Nov; 13(6):1149-1153. PubMed ID: 30943787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial.
    Bubner TK; Laurence CO; Gialamas A; Yelland LN; Ryan P; Willson KJ; Tideman P; Worley P; Beilby JJ
    Med J Aust; 2009 Jun; 190(11):624-6. PubMed ID: 19485840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-Care Hemoglobin A1c Testing: An Evidence-Based Analysis.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2014; 14(8):1-30. PubMed ID: 26316922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(12):1-114. PubMed ID: 23074516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of StatSensor Point-of-Care Device for Measuring Creatinine in Patients With Chronic Kidney Disease and Postkidney Transplantation.
    Nataatmadja M; Fung AWS; Jacobson B; Ferera J; Bernstein E; Komenda P; Mattman A; Seccombe D; Levin A
    Can J Kidney Health Dis; 2020; 7():2054358120970716. PubMed ID: 33240520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio.
    Shephard MD; Allen GG; Paizis K; Barbara JA; Batterham M; Vanajek A
    Rural Remote Health; 2006; 6(4):591. PubMed ID: 17022724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in the Quality of HbA1c Determination by Using Commutable Specimens With IFCC-Assigned Values.
    Zhou R; Gao ZQ; Tong Q; Zuo C; Song ZX; Wang W; Wang QT
    Lab Med; 2017 May; 48(2):148-153. PubMed ID: 28371852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.